About Quanticel
Quanticel is a Healthcare company based in San Diego (United States) founded in 2010, and was acquired by Celgene in April 2015. Biopharmaceutical products for serious diseases are discovered and developed. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
Quanticel was founded in 2010 in San Diego, United States, within the biopharmaceutical sector. Medicines for various diseases are discovered, developed, and delivered through research and development efforts across multiple treatment modalities and scientific platforms. Resources are provided for patients and healthcare providers, including details on medicines, clinical trials, and support programs. Operations are centered on advancing therapies for serious conditions.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website quanticel.com
- Social LinkedIn
- Acquired by Celgene (Apr 2015)
Investors in Quanticel
Quanticel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Celgene.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapies for cancer and inflammatory diseases are developed. | 1986 | celgene.com | Summit, United States |
Investor details for Quanticel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Quanticel
2 dated milestones of Quanticel across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Quanticel is founded.
- Exit Acquired by Celgene.
Top companies in Oncology
3 companies that operate in the same segment as Quanticel (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Quanticel
Quanticel was founded in 2010.
Quanticel is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Quanticel was founded in 2010 in San Diego, United States, within the biopharmaceutical sector. Medicines for various diseases are discovered, developed, and delivered through research and development efforts across multiple treatment modalities and scientific platforms. Resources are provided for patients and healthcare providers, including details on medicines, clinical trials, and support programs. Operations are centered on advancing therapies for serious conditions.
Quanticel has 1 investor. Key investors include Celgene.
Yes. Quanticel was acquired by Celgene in April 2015.